Interest in cardiac amyloidosis has been on the rise in recent years. Jamie Bourque, MD, talked to Cardiovascular Business about an upcoming consensus statement focused on using cardiac imaging to evaluate patients for signs of this serious condition. 

The radiation doses associated with CT have decreased significantly, leaving nuclear cardiology as the modality with the highest doses in all of cardiac imaging. Rob deKemp, PhD, talked to us about some of the many ways imagers can work to address this issue.

On Target Laboratories will use the funding to expand the market reach of its molecular imaging agent.

The new facility is run by Novartis and is being called the “most advanced of its kind."

Bhvita Jani, medical imaging principal analyst at Signify Research, discusses the evolution of theragnostics and its applications in nuclear imaging and oncology.

Supply chain disruptions are blamed for the lack of production.

Images from the world's largest radiology conference include new technologies and the latest advances in MRI, CT, nuclear medicine, X-ray, artificial intelligence, and PACS/enterprise imaging.

Outdated infrastructure and a lack of young people entering the field are both impacting the security of critical isotopes such as molybdenum-99.